StemMedical aims to partner with leading academic institutions and companies working within the osteoarthritis space. Together we aim to develop a best in class stem-cell based therapy for the treatment of osteoarthritis.
We're looking for potential partners
The StemMedical platform is unique within MSC production given its ability to produce potent MSCs in 10-20 billion batches (autologous or allogenic), and can address multiple application areas. StemMedical is looking for public and private partners to accelerate the development of new therapeutic indications with our unique stem cell-based technology.
If you are interested and would like to meet us, fill in below form and we will contact you.